Cart is empty The U.S. Food and Drug Administration has approved Eli Lilly’s Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.
The U.S. Food and Drug Administration has approved Eli Lilly’s Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.
Leave A Comment